Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Immunobiology and the future of myoblast transfer therapy.

Smythe GM, Hodgetts SI, Grounds MD.

Mol Ther. 2000 Apr;1(4):304-13. Review.

PMID:
10933948
[PubMed - indexed for MEDLINE]
Free Article
3.

Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells.

Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD.

Cell Transplant. 2000 Jul-Aug;9(4):489-502.

PMID:
11038066
[PubMed - indexed for MEDLINE]
4.

Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.

Qu Z, Huard J.

Gene Ther. 2000 Mar;7(5):428-37.

PMID:
10694825
[PubMed - indexed for MEDLINE]
Free Article
5.

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism.

Camirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP.

Am J Transplant. 2004 Aug;4(8):1255-65. Erratum in: Am J Transplant. 2005 Dec;5(12):3024.

PMID:
15268726
[PubMed - indexed for MEDLINE]
Free Article
6.

A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.

Li S, Kimura E, Ng R, Fall BM, Meuse L, Reyes M, Faulkner JA, Chamberlain JS.

Hum Mol Genet. 2006 May 15;15(10):1610-22. Epub 2006 Apr 4.

PMID:
16595609
[PubMed - indexed for MEDLINE]
Free Article
7.

[Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].

Zhang C, Feng HY, Huang SL, Fang JP, Xiao LL, Yao XL, Chen C, Ye X, Zeng Y, Lu XL, Wen JM, Zhang WX, Li Z, Feng SW, Xu HG, Huang K, Zhou DH, Chen W, Xie YM, Xi J, Zhang M, Li Y, Liu Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Aug;22(4):399-405. Chinese.

PMID:
16086277
[PubMed - indexed for MEDLINE]
8.

Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.

Ikezawa M, Cao B, Qu Z, Peng H, Xiao X, Pruchnic R, Kimura S, Miike T, Huard J.

Hum Gene Ther. 2003 Nov 1;14(16):1535-46.

PMID:
14577915
[PubMed - indexed for MEDLINE]
9.

Myoblast transfer therapy: is there any light at the end of the tunnel?

Mouly V, Aamiri A, Périé S, Mamchaoui K, Barani A, Bigot A, Bouazza B, François V, Furling D, Jacquemin V, Negroni E, Riederer I, Vignaud A, St Guily JL, Butler-Browne GS.

Acta Myol. 2005 Oct;24(2):128-33. Review.

PMID:
16550930
[PubMed - indexed for MEDLINE]
10.

Problems and solutions in myoblast transfer therapy.

Smythe GM, Hodgetts SI, Grounds MD.

J Cell Mol Med. 2001 Jan-Mar;5(1):33-47. Review.

PMID:
12067449
[PubMed - indexed for MEDLINE]
11.

Development of therapy for Duchenne muscular dystrophy.

Zhang S, Xie H, Zhou G, Yang Z.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Feb;21(2):194-203. Review.

PMID:
17357471
[PubMed - indexed for MEDLINE]
12.

Cell based therapy for Duchenne muscular dystrophy.

Farini A, Razini P, Erratico S, Torrente Y, Meregalli M.

J Cell Physiol. 2009 Dec;221(3):526-34. doi: 10.1002/jcp.21895. Review.

PMID:
19688776
[PubMed - indexed for MEDLINE]
13.

[Cell therapy for Duchenne muscular dystrophy].

Zhou C, Zhang C.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Dec;23(6):659-61. Review. Chinese.

PMID:
17160947
[PubMed - indexed for MEDLINE]
14.

A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation.

Hodgetts SI, Spencer MJ, Grounds MD.

Transplantation. 2003 Mar 27;75(6):863-71.

PMID:
12660516
[PubMed - indexed for MEDLINE]
15.

Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?

Wells DJ, Wells KE.

Neuromuscul Disord. 2002 Oct;12 Suppl 1:S11-22. Review.

PMID:
12206790
[PubMed - indexed for MEDLINE]
16.

Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy.

Ferrer A, Wells KE, Wells DJ.

Gene Ther. 2000 Sep;7(17):1439-46.

PMID:
11001363
[PubMed - indexed for MEDLINE]
Free Article
17.

Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.

Law PK, Goodwin TG, Fang Q, Duggirala V, Larkin C, Florendo JA, Kirby DS, Deering MB, Li HJ, Chen M, et al.

Cell Transplant. 1992;1(2-3):235-44.

PMID:
1344295
[PubMed - indexed for MEDLINE]
18.

A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy.

Rodino-Klapac LR, Janssen PM, Montgomery CL, Coley BD, Chicoine LG, Clark KR, Mendell JR.

J Transl Med. 2007 Sep 24;5:45.

PMID:
17892583
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Gene therapy progress and prospects: Duchenne muscular dystrophy.

Foster K, Foster H, Dickson JG.

Gene Ther. 2006 Dec;13(24):1677-85. Epub 2006 Oct 26. Review.

PMID:
17066097
[PubMed - indexed for MEDLINE]
20.

Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy.

Sammels LM, Bosio E, Fragall CT, Grounds MD, van Rooijen N, Beilharz MW.

Transplantation. 2004 Jun 27;77(12):1790-7.

PMID:
15223893
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk